Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1993 Aug;70(2):150–153. doi: 10.1136/hrt.70.2.150

Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state.

M P van den Berg 1, H J Crijns 1, A T Gosselink 1, S A van den Broek 1, H J Hillege 1, D J van Veldhuisen 1, K I Lie 1
PMCID: PMC1025276  PMID: 7913614

Abstract

OBJECTIVE--To determine the relation between functional capacity and heart rate response to exercise in patients with atrial fibrillation. SUBJECTS--73 consecutive patients with chronic atrial fibrillation. MAIN OUTCOME MEASURES--Relation between functional capacity, measured as peak oxygen consumption (peak VO2; ml/min/kg), and heart rate at all stages of exercise in univariate and multivariate analyses. RESULTS--Peak VO2 showed no correlation with resting heart rate, but it showed a negative correlation with heart rate during the first stage of exercise (r = -0.94, p < 0.01). Indeed, heart rate during the early stages of exercise (stages 1-5) was higher in patients with a peak VO2 less than or equal to 20 ml/mm/kg than in those with a peak VO2 greater than 20 ml/min/kg (heart rate 140 v 125 beats/min, p < 0.05). At maximal exercise, however, peak VO2 was positively correlated with heart rate (r = 2.15, p < 0.0001). CONCLUSION--In patients with atrial fibrillation and impaired functional capacity heart rate at low levels of exercise is augmented but maximal heart rate attenuated compared with patients with preserved functional capacity. Excessive heart rate responses to minor exercise may have deleterious effects on left ventricular function and thereby further limit functional capacity.

Full text

PDF
150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberg H., Ström G., Werner I. Heart rate during exercise in patients with atrial fibrillation. Acta Med Scand. 1972 Apr;191(4):315–320. [PubMed] [Google Scholar]
  2. Andersson B., Blomström-Lundqvist C., Hedner T., Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 1991 Oct;18(4):1059–1066. doi: 10.1016/0735-1097(91)90767-4. [DOI] [PubMed] [Google Scholar]
  3. Atwood J. E., Myers J., Sullivan M., Forbes S., Friis R., Pewen W., Callaham P., Hall P., Froelicher V. Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation. J Am Coll Cardiol. 1988 Mar;11(3):508–513. doi: 10.1016/0735-1097(88)91524-0. [DOI] [PubMed] [Google Scholar]
  4. Atwood J. E., Sullivan M., Forbes S., Myers J., Pewen W., Olson H. G., Froelicher V. F. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol. 1987 Aug;10(2):314–320. doi: 10.1016/s0735-1097(87)80013-x. [DOI] [PubMed] [Google Scholar]
  5. CHIDSEY C. A., HARRISON D. C., BRAUNWALD E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962 Sep 27;267:650–654. doi: 10.1056/NEJM196209272671305. [DOI] [PubMed] [Google Scholar]
  6. Corbalán R., Jalil J., Chamorro G., Casanegra P., Valenzuela P. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure. Am J Cardiol. 1990 Mar 1;65(9):644–649. doi: 10.1016/0002-9149(90)91045-8. [DOI] [PubMed] [Google Scholar]
  7. Francis G. S., Goldsmith S. R., Ziesche S. M., Cohn J. N. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol. 1982 Apr 1;49(5):1152–1156. doi: 10.1016/0002-9149(82)90039-x. [DOI] [PubMed] [Google Scholar]
  8. Grogan M., Smith H. C., Gersh B. J., Wood D. L. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992 Jun 15;69(19):1570–1573. doi: 10.1016/0002-9149(92)90705-4. [DOI] [PubMed] [Google Scholar]
  9. Hammond H. K., Froelicher V. F. Normal and abnormal heart rate responses to exercise. Prog Cardiovasc Dis. 1985 Jan-Feb;27(4):271–296. doi: 10.1016/0033-0620(85)90010-6. [DOI] [PubMed] [Google Scholar]
  10. Heinz G., Siostrzonek P., Kreiner G., Gössinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 1992 Feb 15;69(5):489–492. doi: 10.1016/0002-9149(92)90991-7. [DOI] [PubMed] [Google Scholar]
  11. Hornsten T. R., Bruce R. A. Effects of atrial fibrillation on exercise performance in patients with cardiac disease. Circulation. 1968 Apr;37(4):543–548. doi: 10.1161/01.cir.37.4.543. [DOI] [PubMed] [Google Scholar]
  12. Kadish A. H., Chen R. F., Schmaltz S., Morady F. Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. J Am Coll Cardiol. 1990 Nov;16(5):1240–1245. doi: 10.1016/0735-1097(90)90560-c. [DOI] [PubMed] [Google Scholar]
  13. Lewis R. V., McMurray J., McDevitt D. G. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J Cardiovasc Pharmacol. 1989 Jan;13(1):1–6. doi: 10.1097/00005344-198901000-00002. [DOI] [PubMed] [Google Scholar]
  14. Lundström T., Rydén L. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. J Am Coll Cardiol. 1990 Jul;16(1):86–90. doi: 10.1016/0735-1097(90)90461-w. [DOI] [PubMed] [Google Scholar]
  15. Mulligan I. P., Fraser A. G., Lewis M. J., Henderson A. H. Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure. Br Heart J. 1989 Jan;61(1):23–28. doi: 10.1136/hrt.61.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nemanich J. W., Veith R. C., Abrass I. B., Stratton J. R. Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol. 1990 Oct 1;66(10):843–848. doi: 10.1016/0002-9149(90)90362-5. [DOI] [PubMed] [Google Scholar]
  17. Patterson J. A., Naughton J., Pietras R. J., Gunnar R. M. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Am J Cardiol. 1972 Nov;30(7):757–762. doi: 10.1016/0002-9149(72)90151-8. [DOI] [PubMed] [Google Scholar]
  18. Rawles J. M. What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J. 1990 Mar;63(3):157–161. doi: 10.1136/hrt.63.3.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Redfors A. Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation. Acta Med Scand. 1971 Oct;190(4):321–333. doi: 10.1111/j.0954-6820.1971.tb07437.x. [DOI] [PubMed] [Google Scholar]
  20. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980 Aug;44(2):117–133. doi: 10.1136/hrt.44.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Weber K. T., Kinasewitz G. T., Janicki J. S., Fishman A. P. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982 Jun;65(6):1213–1223. doi: 10.1161/01.cir.65.6.1213. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES